Cargando…
Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses
BACKGROUND: Cardiac troponin-I assays have been validated in horses.’High-sensitivity’ cardiac troponin assays are now the standard in human cardiology. Objective: Appropriately validate the’high-sensitivity’ cardiac Troponin-T (hscTnT) assay for clinical use in horses, establish reference intervals...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906598/ https://www.ncbi.nlm.nih.gov/pubmed/27296016 http://dx.doi.org/10.1186/s12917-016-0737-1 |
_version_ | 1782437438250024960 |
---|---|
author | Shields, E. Seiden-Long, I. Massie, S. Passante, S. Leguillette, R. |
author_facet | Shields, E. Seiden-Long, I. Massie, S. Passante, S. Leguillette, R. |
author_sort | Shields, E. |
collection | PubMed |
description | BACKGROUND: Cardiac troponin-I assays have been validated in horses.’High-sensitivity’ cardiac troponin assays are now the standard in human cardiology. Objective: Appropriately validate the’high-sensitivity’ cardiac Troponin-T (hscTnT) assay for clinical use in horses, establish reference intervals, determine the biological variation, and demonstrate assay utility in selected clinical cases. Methods: Analytical validation of the Roche hscTnT assay included within- and between-run precision, linear dose response, limit of quantitation (LoQ), stability, and comparison with cTn-I (iSTAT). Reference intervals and biological variation were determined using adult, healthy, Non-Competition Horses (N = 125) and Racing-Thoroughbreds (N = 178). HscTnT levels were measured in two horses with cardiac pathology. RESULTS: The hscTnT demonstrates acceptable within-run (L1 = 6.5 ng/L, CV 14.9 %, L2 = 10.1 ng/L, CV 8.7 %, L3 = 15.3 ng/L, CV 5.4 %) and between-run precision (L1 = 12.2 ng/L, CV 8.4 %, L2 = 57.0 ng/L, CV 8.4 %, L3 = 256.0 ng/L, CV 9.0 %). The assay was linear from 3 to 391 ng/L. The LoQ was validated at 3 ng/L. Samples demonstrated insignificant decay over freeze-thaw cycle. Comparison with cTnI assay showed excellent correlation (range: 8.0–3535.0 ng/L, R(2) = 0.9996). Reference intervals: The upper 95(th) and 99(th) percentile of the hscTnT population distribution were 6.8 and 16.2 ng/L in Non-Competition Horses, and 14.0 and 23.2 ng/L in Racing-Thoroughbreds. Between-breed, diurnal effect, and between-day variation was below LoQ. Two clinical cases with presumed cardiac pathology had hscTnT levels of 220.9 ng/L and 5723.0 ng/L. CONCLUSIONS: This benchmark study is the first to comply with CLSI guidelines, thus further establishing the performance characteristics of the hscTnT assay, and reference intervals in healthy horses. Two clinical cases demonstrated further the clinical utility of the assay. |
format | Online Article Text |
id | pubmed-4906598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49065982016-06-15 Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses Shields, E. Seiden-Long, I. Massie, S. Passante, S. Leguillette, R. BMC Vet Res Research Article BACKGROUND: Cardiac troponin-I assays have been validated in horses.’High-sensitivity’ cardiac troponin assays are now the standard in human cardiology. Objective: Appropriately validate the’high-sensitivity’ cardiac Troponin-T (hscTnT) assay for clinical use in horses, establish reference intervals, determine the biological variation, and demonstrate assay utility in selected clinical cases. Methods: Analytical validation of the Roche hscTnT assay included within- and between-run precision, linear dose response, limit of quantitation (LoQ), stability, and comparison with cTn-I (iSTAT). Reference intervals and biological variation were determined using adult, healthy, Non-Competition Horses (N = 125) and Racing-Thoroughbreds (N = 178). HscTnT levels were measured in two horses with cardiac pathology. RESULTS: The hscTnT demonstrates acceptable within-run (L1 = 6.5 ng/L, CV 14.9 %, L2 = 10.1 ng/L, CV 8.7 %, L3 = 15.3 ng/L, CV 5.4 %) and between-run precision (L1 = 12.2 ng/L, CV 8.4 %, L2 = 57.0 ng/L, CV 8.4 %, L3 = 256.0 ng/L, CV 9.0 %). The assay was linear from 3 to 391 ng/L. The LoQ was validated at 3 ng/L. Samples demonstrated insignificant decay over freeze-thaw cycle. Comparison with cTnI assay showed excellent correlation (range: 8.0–3535.0 ng/L, R(2) = 0.9996). Reference intervals: The upper 95(th) and 99(th) percentile of the hscTnT population distribution were 6.8 and 16.2 ng/L in Non-Competition Horses, and 14.0 and 23.2 ng/L in Racing-Thoroughbreds. Between-breed, diurnal effect, and between-day variation was below LoQ. Two clinical cases with presumed cardiac pathology had hscTnT levels of 220.9 ng/L and 5723.0 ng/L. CONCLUSIONS: This benchmark study is the first to comply with CLSI guidelines, thus further establishing the performance characteristics of the hscTnT assay, and reference intervals in healthy horses. Two clinical cases demonstrated further the clinical utility of the assay. BioMed Central 2016-06-13 /pmc/articles/PMC4906598/ /pubmed/27296016 http://dx.doi.org/10.1186/s12917-016-0737-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Shields, E. Seiden-Long, I. Massie, S. Passante, S. Leguillette, R. Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses |
title | Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses |
title_full | Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses |
title_fullStr | Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses |
title_full_unstemmed | Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses |
title_short | Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses |
title_sort | analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-t assay in horses |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906598/ https://www.ncbi.nlm.nih.gov/pubmed/27296016 http://dx.doi.org/10.1186/s12917-016-0737-1 |
work_keys_str_mv | AT shieldse analyticalvalidationandestablishmentofreferenceintervalsforahighsensitivitycardiactroponintassayinhorses AT seidenlongi analyticalvalidationandestablishmentofreferenceintervalsforahighsensitivitycardiactroponintassayinhorses AT massies analyticalvalidationandestablishmentofreferenceintervalsforahighsensitivitycardiactroponintassayinhorses AT passantes analyticalvalidationandestablishmentofreferenceintervalsforahighsensitivitycardiactroponintassayinhorses AT leguilletter analyticalvalidationandestablishmentofreferenceintervalsforahighsensitivitycardiactroponintassayinhorses |